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Abstract
Background: Cervical cancer is the second most common cancer in females. Recent reports have revealed the
critical role of cervical cancer stem cells (CSCs) in tumorigenicity and metastasis. Previously we demonstrated that
A1E exerts an anti-proliferative action, which inhibits the growth of cervical cancer cells.
Methods: A1E is composed of 11 oriental medicinal herbs. Cervical cancer cell culture, wund healing and invasion
assay, flow cytometry, sheroid formation assay, and wstern blot assays were performed in HPV 16-positive SiHa cell
and HPV 16-negative C33A cells.
Results: A1E targets the E6 and E7 oncogenes; thus, A1E significantly inhibited proliferation of human papilloma
virus (HPV) 16-positive SiHa cells, it did not inhibit the proliferation of HPV-negative C33A cells. Accordingly,
we investigated whether A1E can regulate epithelial-to-mesenchymal transition (EMT), CSC self-renewal, and
stemness-related gene expression in cervical cancer cells. Down rgulation of cell migration, cell invasion, and
EMT was observed in A1E-treated SiHa cells. Specifically, A1E-treated SiHa cells showed significant decreases
in OCT-3/4 and Sox2 expression levels and in sphere formation. Moreover, CSCs makers ALDH+ and ALDH,
CD133 double positive cell were significantly decreased in A1E-treated SiHa cells. However, A1E treatment did
not down regulate ALDH+ expression and the number of ALDH/CD133 double positive cells in C33A cells.
Conclusions: Taken together, A1E can inhibit CSCs and reduce the expression of stemness markers. Treating
CSCs with A1E may be a potential therapy for cervical cancer.
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Background
Cervical cancer is the second most common cancer
in women worldwide, despite many steps taken to re-
duce disease burden in past decades [1]. Infection
with HPV subtypes such as HPV 16, 18, 31, and 33
greatly increases the risk of cancer and plays a central
role in the development of ~99.5 % of cervical cancers [2].
The E6 and E7 oncoproteins have been shown to be main
mediators of the development of HPV-induced cervical
carcinoma [3]. The cancer stem cell (CSC) hypothesis
states that a tumor has a hierarchical cellular structure in
which only a small subpopulation, referred to as cancer
stem cells, is capable of tumorigenesis [4]. CSCs possess
stem cell-like properties of self-renewal and can differenti-
ate into non-stem tumor cells. CSCs have been reported
in multiple types of solid tumor and in cultured cancer
cell lines, including brain, breast, colon prostate, and
cervical cancer cell lines [5]. CSCs have been identified
and characterized in cervical cancer cell lines, but there
are hardly any reports of CSCs in samples from patients
with cervical cancer [6]. ALDH, CD133, and Sox2 have
been identified as the first putative CSC markers in
human cervical carcinoma [6]. A study demonstrated the
use of CD44 and cytokeratin 17 cell surface markers to
enrich a cervical CSC population [3]. Further, another
investigation revealed that an enriched cervical cancer
cellular pool possesses tumorigenic capacity and expresses
stemness-related genes (Oct-3/4 and Sox2) [7]. Moreover,
CSCs are responsible for cancer recurrence. Based on
these reports, further cancer therapies might focus on
the elimination of CSCs [8]. Moreover, epithelial-to-
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mesenchymal transition (EMT) is a major cause of
CSC progression and differentiation [9]. Hence, devel-
opment of innovative therapeutics is required. Herbal
medicines have been used to treat various diseases
since ancient times in many Asian countries. Herbal
medicines are extracted from traditional Asian medical
plants and have therapeutic activities against cancers,
angiogenesis, and metastasis in the absence of observable
in vivo side effects [10]. Previously we reported that A1E,
an extract formulated from 11 Asian traditional medicinal
plants, consists of several compounds that target pathways
such as the E6 and E7 pathway and mitochondrial in-
trinsic pathway. A1E inhibits E6 and E7 oncogenes
and induces intrinsic apoptosis via p53/pRb dependent
pathways and a mitochondria-mediated pathway [11].
Furthermore, A1E induces apoptosis via activation of both
extrinsic and intrinsic pathways and the inhibition of
PI3K/Akt survival signaling pathways in lung cancer cells
[12]. Based on these data, we investigated whether A1E
can regulate EMT, CSC self-renewal, and stemness-related
gene expression in cervical cancer cells. Our data suggest
that A1E can inhibit CSCs and reduce the expression of
stemness markers. Treating CSCs with A1E may be a
potential therapy for cervical cancer.
Methods
A1E formulation
A1E is composed of 11 oriental medicinal herbs (Table 1).
We previously determined proportions (w/w) of these
herbs in A1E as follows [12] and used the same batch for
analysis in this study: 15.8 % ginseng (Korea), 15.8 %
Chaga (Russia), 10.6 % Pinellia tuber (China), 10.6 %
Psoraleae semen (India), 5.2 % Alpinia rhizome (China),
5.2 % Sparganium rhizome (China), 5.2 % cinnamon
bark (Vietnam), 5.2 % Astragalus root (Korea), 5.2 %
Alpiniakatsumadai seed (Vietnam), 10.6 % Arisaema rhi-
zome (China), and 10.6 % Dolichos seed (China). The
herbal ingredients were obtained from Oriental Medical
Hospital of Dongkuk University Ilsan, Korea) and kindly
authenticated by Dr. Jeong Seong hyun (Department of
Oriental Herbal Materials, Dongkuk University). Extrac-
tion of A1E and constituent herbs. The ethanol extract
was prepared as follows: The dried and pulverized medi-
cinal herbs were mixed together and 1 Kg batch was
soaked with 40 % ethanol (3 liters) the ethanol extract was
concentrated with a rotary evaporator, and lyophilized,
and reconstituted in either dimethysulfoxide (DMSO)
for the in vitro studies. Additional procedures were per-
formed as described previously [12].
Cell culture
The HPV 16-positive SiHa and the HPV-negative C33A
cervical cancer cell lines were obtained from the American
Type Culture Collection (USA). The cells were maintained
in Dulbecco’s modified Eagle’s medium (DMEM, Invitro-
gen) containing 10 % fetal bovine serum (FBS, HyClone,
South Logan, UT, USA), penicillin (100 U/ml), and strepto-
mycin (100 mg/ml).
Wound healing and invasion assay
Wound healing and invasion assay were performed as
described previously [13]. Images of SiHa and C33A cells
migrating into the wound were captured at time points
of 0 and 24 h by an inverted microscope (40×).
Flow cytometry analyses
The ALDEFLUOR assay (STEMCELL Technologies,
Vancouver, Canada) was performed as described previously
[13]. As a negative control, an aliquot of ALDEFLUOR-
exposed cells was immediately quenched with a specific
ALDH inhibitor, diethylaminobenzaldehyde (DEAB).
Following 30 min incubation at 37 °C, cells were washed
and analyzed by FACSCalibur (Becton Dickinson, MD,
USA).
Spheroid formation assay
Wound healing and invasion assays were performed as
described previously [13]. After 10 ~ 14 days, the number
of SiHa and C33A cell spheroids (tight, spherical, non-
adherent masses with >60 μm diameter) were counted,
and spheres were imaged under an inverse microscope.
Spheroid formation efficiency (%) = colonies/input cells ×
100.
Western blot analysis
We homogenized cell lysates in a lysis buffer (20 mM
HEPES, 150 mM NaCl, 2 mM EGTA, 1 mM EDTA,
20 mM glycerol phosphate, 1 % Triton X-100, and 10 %
glycerol with protease Sigma) and a phosphatase-inhibitor
Table 1 The composition of A1E
Oriental name Country of origin Grams %
Ginseng Korea 158 15.8
Chaga Russia 158 15.8
Pinellia tuber China 106 10.6
Psoraleae semen India 106 10.6
Alpinia rhizome China 52 5.2
Sparganium rhizome China 52 5.2
Cinnamon bark Vietnam 52 5.2
Astragalus root Korea 52 5.2
Alpiniakatsumadai seed Vietnam 52 5.2
Arisaema rhizome China 106 10.6
Dolichos seed China 106 10.6
Total amount 1000 100
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cocktail (Roche). Additional details were performed as
described previously [14]. Membranes were primarily
blotted with primary antibodies against GAPDH (AbFron-
tier); E-cadherin, β-catenin, vimentin, and Sox2 (Cell Sig-
naling Technology); and OCT-3/4 (Abcam).
Statistical analysis
Statistical analysis was performed using an ANOVA test
and determination of the Pearson’s correlation coeffi-
cient on SigmaPlot 12.3 software. A p value of <0.05 was
considered significant.
Results
A1E inhibited EMT in HPV 16-positive cervical carcinoma
cells
Previously we demonstrated that A1E is cytotoxic against
SiHa cells n vitro with an estimated significant effect on
cell viability at 0.125 mg/ml [11]. Moreover, A1E per-
turbed cell cycle progression at the sub-G1 phase and
altered cell cycle regulatory factors in SiHa cells. A1E
activated apoptotic intrinsic pathway markers such as
caspase-9, caspase-3, and poly (ADP-ribose) polymerase
and down-regulated expression of Bcl-2 and Bcl-xl. A1E
induced mitochondrial membrane potential collapse and
Fig. 1 A1E reduces EMT in cervical carcinoma cells. a Wound healing and invasion assays of HPV 16-positive SiHa cells. b Wound healing assays of
HPV-negative C33A cells. Data are presented as mean ± SEM. *P < 0.05. c Western blotting analysis of EMT markers in A1E-treated SiHa and C33A cells
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cytochrome c release and inhibited phosphatidylinositol
3-kinase (PI3K)/Akt, which are key factors involved in cell
survival signaling [11]. A1E exerts an anti-proliferative
action, which inhibits the growth of cervical cancer cells
through apoptosis, that demonstrates its anti-cervical
cancer properties [15]. Based on these data, we character-
ized stemness-associated properties of HPV 16-positive
SiHa and HPV 16-negative C33A cervical carcinoma cells
and examined the effect of A1E on these properties. A1E
targets E6 and E7 oncogenes; thus, A1E significantly
inhibited proliferation of SiHa cells, whereas it did not
affect proliferation of C33A cells that were only slightly
affected by A1E [11]. This indicates very low expression
levels of E6 and E7 oncogenes in C33A cells [16]. On
examination of wound healing and invasion activities, we
found that A1E reduced both activities in SiHa cells
(Fig. 1a), but did not reduce wound healing activities in
C33A cells (Fig. 1b). We next investigated whether A1E
can regulate EMT, which is a major cause of tumor pro-
gression that causes cell migration and invasion, allows
tumor metastasis, and establishes secondary tumors at
distant sites [17]. A1E-treated HPV 16-positive SiHa cells
showed significantly increased E-cadherin and decreased
vimentin expression levels. However, A1E-treated HPV
16-negative C33A cells showed significantly decreased
E-cadherin expression levels and unchanged vimentin
expression levels (Fig. 1c). These data suggest that A1E
negatively regulates EMT in HPV 16-positive SiHa cells.
Fig. 2 A1E regulates stemness in cervical carcinoma cells. a Spheroid formation assay of A1E-treated HPV 16-positive SiHa cells grown in stem cell
selective media for 0, 7, and 14 days. b Spheroid formation assay of A1E-treated HPV-negative C33A cells grown in stem cell selective media for
14 days (magnification, 100×). Bar represents 50 μm. Histogram shows the average number of spheroids formed from 2000 cells. Data are presented as
mean ± SEM. **P < 0.01. c Western blotting analysis of stemness markers in A1E-treated SiHa and C33A cells
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A1E reduced CSCs self-renewal in HPV 16-positive cervical
carcinoma cells
Cultured CSCs can generate floating spheroid bodies
[18]. Thus, we next investigated whether spheroid for-
mation occurs in A1E-treated cervical cancer cells. In
A1E-treated HPV 16-positive SiHa cell cultures, spher-
oid formation was observed within 0, 7, and 14 days,
indicating that SiHa cells possess a significant propor-
tion of CSCs (Fig. 2a). However, in A1E-treated HPV 16-
negative C33A cells, regulation of spheroid formation
(Fig. 2b) and stemness-related gene expression (Fig. 2c)
was not observed. It has been reported that SiHa cells
show significant expressions of stemness markers such
as β-catenin and stemness-related genes such as Oct-3/4
and Sox2 [7]. Our data indicate that A1E-treated HPV
16-positive SiHa cells down-regulated sphere formation
and β-catenin expression and slightly decreased stemness
gene (OCT-3/4 and Sox2) expression (Fig. 2c). Taken
Fig. 3 A1E regulates ALDH and CD133 positive expression in cervical carcinoma cells. a FACS analysis was performed on A1E-treated or
untreated HPV 16-positive SiHa cells. b FACS analysis was performed on A1E-treated or untreated HPV-negative C33A cells. Data are
presented as mean ± SEM. *P < 0.05
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together, A1E treatments inhibited spheroid formation
and regulated OCT-3/4 and Sox2 expressions. These data
suggest that A1E suppresses the self-renewal activity of
the CSC subpopulation in HPV 16-positive SiHa cells.
ALDH and CD 133 expression in A1E-treated cervical
cancer cells
In recent reports, ALDH1 has been considered a marker
for CSCs. ALDH activity has been used to isolate CSCs
from cervical cancer cell lines and primary cervical
cancer cells because ALDH+ cervical cancer cells pos-
sess self-renewal and differentiation abilities and have
enhanced tumorigenicity [19]. The ALDEFLUOR kit
was used to test ALDH enzymatic activity in HPV 16-
positive SiHa and HPV 16-negative C33A cervical cancer
cell lines. Cells were labeled with the activated ALDE-
FLUOR reagent in the presence or absence of the ALDH
inhibitor, DEAB. A drop of ALDEFLUOR-labeled cells
was examined by FACS Calibur [19]. We found that the
numbers of ALDH+ and ALDH/CD133 double-positive
cells were significantly decreased in A1E-treated SiHa
cells than in untreated SiHa cells (Fig. 3a). Moreover,
A1E treatment did not affect ALDH+ and ALDH/
CD133 double-positive expression in HPV 16-negative
C33A cells (Fig. 3b). These data indicate that A1E-
treated SiHa cells have lower self-renewal capacity
compared to untreated SiHa cells.
Discussion
HPV is implicated in virtually all cervical cancers world-
wide, with HPV 16 being the most common high-risk
HPV type [2]. Since the discovery of the role of HPV in
cervical cancer, many techniques have been developed to
identify HPV infection and have been tested by screen-
ing patient groups [20]. It has been shown that results of
HPV tests predict the risk of cervical cancer and its
precursors better and sooner than examinations of cyto-
logical abnormalities [21]. Recent studies have revealed
the critical role of CSCs in tumorigenicity and metastasis
[4]. To date, CSCs have been identified in numerous
solid cancers including breast and cervical cancers [19].
Moreover, CSCs are responsible for cancer recurrence.
Based on these reports, further cancer therapies might
focus on the elimination of CSCs [8]. Furthermore,
development of innovative therapeutics for the treat-
ment of cervical cancer is required.
Previously we assessed molecular mechanisms involved
in anticancer effects of A1E [12]. A1E is composed of
ethanol extracts from mixtures of ginseng, Pinellia
tuber, Chaga, Alpinia rhizome, Sparganium rhizome,
Alpiniakatsumadai seed, Arisaema rhizome, Psoraleae
semen, cinnamon bark, and Dolichos seed [12]. A1E
treatment significantly inhibited proliferation of SiHa
cells, whereas it did not inhibit proliferation of CaSki,
C33A, and HaCaT cells. Furthermore, we investigated
whether A1E can regulate cervical CSC self-renewal
in HPV 16-positive SiHa and HPV 16-negative C33A
cervical carcinoma cells. However, A1E-treated SiHa
showed decreased cell wound healing and invasion.
Moreover, A1E-treated SiHa cells inhibited EMT markers
such as E-cadherin and suppressed the expression of β-
catenin. E-cadherin binds to β-catenin to improve cell–
cell adhesion; thus, changes of E-cadherin and β-catenin
expressions are correlated with tumor invasion and metas-
tasis [22]. Additionally, A1E-treated SiHa cells showed
downregulated spheroid formation and slightly decreased
expression of stemness genes OCT-3/4 and Sox2. Notably,
the aberrant expression of certain stem cell-related nu-
clear transcription factors, such as OCT-3/4 and Sox2,
could contribute to cervical carcinogenesis. Sox2 could
enhance the proliferation of cervical cancer cells by
upregulating cyclin D1 expression [23]. We next in-
vestigated ALDH and CD133 activity in HPV 16-positive
SiHa and HPV 16-negative C33A cells. ALDH1 and
CD133 are cancer stem-cell markers and their presence
strongly correlates with tumor malignancy and self-
renewal properties of stem cells in cancers including cer-
vical cancer [19]. Our data show that numbers of ALDH+
and ALDH/CD133 double positive cells were significantly
decreased in A1E-treated SiHa cells. However, A1E treat-
ment did not affect ALDH+ and ALDH/CD133 double
positive expression and self–renewal capacity in HPV 16-
negative C33A cells. Taken together, these data suggest
that A1E extracts may be potentially used in therapies
to suppress CSC self-renewal in HPV 16-positive SiHa
cervical cancer cells.
Conclusions
From the above findings, A1E is composed of 11 oriental
medicinal herbs. A1E negatively regulates EMT in HPV
16-positive SiHa cells. Additionally, A1E-treated SiHa
cells showed downregulated spheroid formation and
slightly decreased expression of stemness genes OCT-3/
4 and Sox2. Therefore, numbers of ALDH+ and ALDH/
CD133 double positive cells were significantly decreased
in A1E-treated SiHa cells. Thus, A1E reduces stemness
and self-renewal in HPV 16-positive cervical CSCs.
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